Aod1 controlling day 3 thymectomy-induced autoimmune ovarian dysgenesis in mice encompasses two linked quantitative trait loci with opposing allelic effects on disease susceptibility.
Day 3 thymectomy (D3Tx) leads to a paucity of CD4(+)CD25(+) suppressor T cells, a loss of peripheral tolerance, and the development of organ-specific autoimmune disease in adult mice. Importantly, D3Tx does not lead to autoimmune disease in all mouse strains, indicating that this process is genetically controlled. Previously, we reported linkage of D3Tx-induced autoimmune ovarian dysgenesis (AOD) and its intermediate phenotypes, antiovarian autoantibody responsiveness, oophoritis, and atrophy, to five quantitative trait loci (QTL), designated Aod1 through Aod5. We also showed interaction between these QTL and H2 as well as Gasa2, a QTL controlling susceptibility to D3Tx-induced autoimmune gastritis. To physically map Aod1, interval-specific bidirectional recombinant congenic strains of mice were generated and studied for susceptibility to D3Tx-induced AOD. Congenic mapping studies revealed that Aod1 controls susceptibility to oophoritis and comprises two linked QTL with opposing allelic effects. Aod1a resides between D16Mit211 (23.3 cM) and D16Mit51 (66.75 cM) on chromosome 16. Aod1b maps proximal of Aod1a between D16Mit89 (20.9 cM) and D16Mit211 (23.3 cM) and includes the candidate genes stefin A1, A2, and A3 (Stfa1-Stfa3), inhibitors of cathepsin S, a cysteine protease required for autoantigen presentation, and the development of autoimmune disease of the salivary and lacrimal glands following D3Tx. cDNA sequencing revealed the existence of structural polymorphisms for both Stfa1 and Stfa2. Given the roles of cathepsins in Ag processing and presentation, Stfa1 and Stfa2 alleles have the potential to control susceptibility to autoimmune disease at the level of both CD4(+)CD25(+) suppressor and CD4(+)CD25(-) effector T cells.
Roper
Randall J
RJ
Department of Veterinary Pathobiology, University of Illinois, Urbana, IL 61802, USA.
McAllister
Ryan D
RD
Biggins
Julia E
JE
Michael
Sandra D
SD
Min
Soo Hong
SH
Tung
Kenneth S K
KS
Call
Stanford B
SB
Gao
Jianfeng
J
Teuscher
Cory
C
D000483:Alleles; D000595:Amino Acid Sequence; D000818:Animals; D000831:Animals, Newborn; D017951:Antigen Presentation / Q000235:genetics; D001324:Autoantigens / Q000276:immunology / Q000378:metabolism; D001327:Autoimmune Diseases / Q000235:genetics* / Q000276:immunology*; D002403:Cathepsins / Q000037:antagonists & inhibitors / Q000502:physiology; D055312:Cystatin A; D015891:Cystatins / Q000235:genetics / Q000302:isolation & purification; D015853:Cysteine Proteinase Inhibitors / Q000235:genetics / Q000302:isolation & purification; D005260:Female; D008040:Genetic Linkage / Q000276:immunology; D020022:Genetic Predisposition to Disease; D008297:Male; D051379:Mice; D020297:Mice, Congenic; D008805:Mice, Inbred A; D008810:Mice, Inbred C57BL; D008969:Molecular Sequence Data; D009869:Oophoritis / Q000235:genetics* / Q000276:immunology*; D020161:Physical Chromosome Mapping; D040641:Quantitative Trait Loci / Q000276:immunology*; D013934:Thymectomy
D001324:Autoantigens; C501463:Csta1 protein, mouse; D055312:Cystatin A; D015891:Cystatins; D015853:Cysteine Proteinase Inhibitors; D002403:Cathepsins; C028217:cathepsin S